查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
生物医学冰箱和冰柜市场 - 增长、趋势、COVID-19 影响和预测 (2023-2028)
市场调查报告书
商品编码
1190080

生物医学冰箱和冰柜市场 - 增长、趋势、COVID-19 影响和预测 (2023-2028)

Biomedical Refrigerator and Freezer Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 117 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在预测期内，生物医学冰箱和冰柜市场预计将以 4.2% 的复合年增长率增长。

COVID-19 大流行扰乱了企业的研发活动。 它还影响了世界各地的治疗方案以及药物和医疗设备供应链，进一步影响了所研究的市场。 根据国家医学图书馆 2021 年 1 月发表的一篇论文，随着疫苗（包括破伤风疫苗）总剂量的下降，疫苗接种覆盖率会下降，导致儿童无法接种疫苗。 同一消息来源说，大流行在三个不同层面上影响了疫苗接种。 对常规免疫接种的影响（包括免疫接种覆盖率、儿科门诊就诊次数）、对大规模或补充免疫接种活动的影响、影响免疫接种覆盖率的因素。 因此，整个市场都受到了 COVID-19 大流行的影响。 然而，由于大流行后的疫苗接种计划，市场有望復苏。

生物医学冰箱和冰柜是主要用于存储生物样本（例如血液、DNA 样本和疫苗）的存储容器。 预计推动生物医学冰箱和冰柜市场增长的主要因素是疾病负担的增加、器官移植需求的增加以及产品技术的发展。 疾病负担的增加和风险因素的增加将是预测期内推动研究领域增长的关键因素。 例如，根据国际糖尿病联合会 (IDF) 2021 年 12 月的一份报告，2021 年约有 5.37 亿 20 至 79 岁的成年人患有糖尿病，其中超过 90% 的人患有 2 型糖尿病，据信患有糖尿病。 糖尿病胰岛素製剂需要持续给药，因此需要长期调节，预计糖尿病患者的增加将增加对活体冷冻机的需求。 2021 年 10 月发布的法国人乳头瘤病毒 (HPV) 和相关疾病报告表明，HPV16 和 18 在成年女性中流行。 4.7%的女性细胞学正常，26.3%患有低度宫颈疾病，60.6%患有高度宫颈疾病，75.6%患有宫颈癌。 HPV 是女性宫颈癌的常见原因。 因此，需要对该疾病进行早期诊断，这将在研究期间推动传染病诊断市场。 因此，这种疾病患病率的增加也将推动市场增长。

然而，生物医学冰箱和冰柜价格昂贵，预计会阻碍市场增长。

主要市场趋势

预计在预测期内市场细分将占据很大份额

增加临床试验和产品发布等因素是市场增长的主要驱动力。 根据 clinicaltrials.gov 的数据，截至 2022 年，大约有 15,316 项涉及生物製药的临床试验在美国註册。 此外，药物评估与研究中心 (CDER) 和食品药品监督管理局 (FDA) 已于 2021 年在全球范围内批准了 50 种药物。 在实验室中使用生物医学冷冻机将药物保持在理想温度是最大限度提高药物活力的重要领域之一。 因此，该国正在研究的药物开发和临床试验的数量正在增加，这有望推动市场的增长。

此外，由于为治疗该疾病开展了广泛的研究活动，COVID-19 大流行一直是推动该领域增长的主要因素之一。 此外，产品发布也是推动市场增长的因素之一。 例如，2021 年 2 月，美国辛辛那提儿童医院医学中心与唐氏综合征（DSA）合作推出了研究生物库。 它将作为唐氏综合症患者及其亲属捐赠的生物样本的中央储存库。 同样，2022年1月，海尔生物医疗将致力于在製造和产品设计上不断创新，为终端用户提供功能、製冷效率和性能更佳的冰柜。 我们还推出了新产品。 例如，2021年6月，海尔生物医疗推出了海尔生物医疗微型超低温冰箱，适用于生物样本库、疫苗接种储运等用户。

因此，由于上述因素，该细分市场将在预测期内增长。

北美将占据很大的市场份额，预计在预测期内也会如此

随着疫苗产量的增加，预计北美将在全球生物医学冰箱和冰柜市场占据很大的市场份额，这可能会增加对药物储存的需求。 根据 ClinicalTrial.gov 的数据，截至 2021 年 4 月，加拿大製药公司和研究机构拥有强大的研发渠道。 该管道包括 5,659 项处于不同评估阶段的新研究。 1,397 个 (24%) 正在进行 FDA 或 EMA 批准的 3 期临床试验，代表了广泛的治疗领域。 因此，越来越多的疫苗需要生物医学冰箱来储存。 人们将生物样本库用于与本国研究相关的各种用途。 例如，2021 年 4 月，从加拿大各地收集了超过 150,000 个样本的 CanPath 开始对安大略健康研究 (OHS) 的 41,000 多名参与者进行基因组测序。 这是利用安大略省癌症研究所 (OICR) 加拿大数据集成中心的基因组技术平台进行的。 这些努力提供了适合支持许多广泛的健康研究应用的研究，科学家们有兴趣在这些应用中识别遗传因素。 这些因素可能与疾病发展和健康老龄化有关，并可能增强我们对基因组如何与疾病发展相关的环境相互作用的理解。 此类应用和上述因素将需要使用生物银行，预计这将在预测期内提高市场增长率。

竞争格局

生物医学冰箱和冰柜市场是分散的，由几家大型企业组成。 目前，一些重要的参与者在市场份额方面占据着市场主导地位。 目前主导市场的公司包括 Thermofisher Scientific Inc.、Terumo Corporation、Arctiko、Foilabo SAS、LabRepCo、Philips Kirsch GmbH、PHC Corporations、Haier Biomedical 和 Helmer Scientific Inc.。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 3 个月的分析师支持

内容

第一章介绍

  • 研究假设和市场定义
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动力
    • 慢性病负担加重
    • 对器官移植和生物製药的需求不断增长
  • 市场製约因素
    • 成本高
  • 波特的五力分析
    • 供应商的议价能力
    • 买方/消费者议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：100 万美元）

  • 按产品类型
    • 等离子冰箱
    • 血库冰箱
    • 实验室冰箱
    • 实验室冰箱
    • 其他
  • 最终用户
    • 医院和诊所
    • 生物样本库
    • 其他
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东和非洲
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲地区
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章竞争格局

  • 公司简介
    • Aegis Scientific Inc.
    • Angelantoni Life Science
    • Arctiko
    • Eppendorf AG
    • Froilabo SAS
    • Haier Biomedical
    • Helmer Scientific Inc.
    • LabRepCo
    • PHC Corporations
    • Philips Kirsch GmbH
    • Terumo Corporation
    • Thermofisher Scientific Inc.

第7章 市场机会与今后动向

简介目录
Product Code: 68193

The biomedical refrigerator and freezer market is expected to register a CAGR of 4.2% over the forecast period.

The COVID-19 pandemic disrupted the research and development activities of companies. Also, it impacted the treatment procedures and supply chain of pharmaceuticals and medical devices worldwide, further impacting the studied market. In January 2021, a paper published in the National Library of Medicine stated that there was a reduction in the total vaccination coverage along with a decline in the total number of vaccines administered (including tetanus vaccines), which led to children missing out on their vaccine doses. ​The same source stated the pandemic had affected immunization on three different levels. Impact on routine immunization (including immunization coverage; and pediatric clinic visits); impact on mass immunizations or supplementary immunization activities; and factors affecting immunization coverage.​ Hence, the overall market has been adversely affected by the COVID-19 pandemic. However, the market is expected to recover in the post-pandemic era due to vaccination programs.

Biomedical refrigerators and freezers are storage containers mainly used to store biological samples such as blood, DNA samples, vaccines, etc. Major factors expected to drive the growth of the biomedical refrigerator and freezer market are the growing disease burden, increasing organ transplantation demand, and the development of technology into products. The rising burden and increased risk factors of diseases will be significant factors driving the growth of the studied segment over the forecast period. For instance, according to the December 2021 report of the International Diabetes Federation (IDF), about 537 million adults of age 20-79 years were living with diabetes in 2021, and more than 90% of this population have Type 2 diabetes. Since the diabetes insulin drug requires to be contained for long periods as the patient requires constant dosage, the increase in diabetes is likely to increase the demand for biomedical freezers. The report "Human Papillomavirus (HPV) and Related Diseases Report France" published in October 2021, suggested HPV 16 and 18 prevalence among adult women. Women with normal cytology are 4.7%, with low-grade cervical lesions is 26.3%, with high-grade cervical lesions is 60.6% and with cervical cancer is 75.6%. HPV is the common cause of cervical cancer among women. Therefore there is a need for early diagnosis of the disease, which will boost the infectious disease diagnostic market during the study period. Thus, the increasing prevalence of the disease will also increase the market growth.

However, biomedical refrigerators and freezers are expensive, which is expected to hamper its market growth.

Key Market Trends

Laboratory Refrigerators Segment is Expected to Hold a Significant Market Share Over the Forecast Period

Factors such as increasing clinical trials and product launches are critical factors in market growth. As per clinicaltrials.gov, around 15,316 clinical trials are presently registered in the US involving biopharmaceuticals in 2022. In addition, the Center for Drug Evaluation and Research (CDER) and Food and Drug Administration (FDA) approved 50 drugs worldwide in 2021. The use of biomedical freezers in the laboratory for maintaining pharmaceuticals at the ideal temperature is one of the essential areas to preserve the viability of the drug at maximum. This increasing number of drug developments and clinical trials studied in the country is anticipated to drive market growth.

Moreover, the COVID-19 pandemic is one of the major factors that drove the segment's growth, as extensive research activities were carried out to treat this disease. Furthermore, product launches are another factor in market growth. For instance, in February 2021, the Cincinnati Children's Hospital Medical Center in the US collaborated with DownSyndrome Achieves (DSA) to launch a research biobank. It serves as a central repository for biospecimens donated by individuals with Down Syndrome and their immediate families.​ Similarly, in January 2022, the chest range of biomedical freezers was revised as part of Haier Biomedical's commitment to ongoing innovation in manufacturing and product design to give end users a freezer with better functionality, cooling efficiency, and performance. The company also launched new products. For instance, in June 2021, Haier Biomedical launched the Haier Biomedical mini ULT freezer, which is suitable for biobanks, vaccination storage, and transportation users.

Thus, the segment will witness growth over the forecast period due to the above factors.​

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

With the increasing vaccine production, North America is expected to hold a significant market share in the global biomedical refrigerator and freezer market, which might increase the demand for drug storage. As of April 2021, according to ClinicalTrial.gov, Canadian pharmaceutical companies and research institutions have robust R&D pipelines. The pipeline contained 5,659 new studies in various stages of evaluation. 1,397 (24%) were in phase III clinical trials, approved through the FDA or EMA, representing a wide range of therapeutic areas. Thus, an increasing number of vaccines require biomedical freezers to store. People use biobanks for various applications related to research studies in the country. For instance, in April 2021, CanPath, with a total specimen of over 150,000 participants from across Canada, started genome sequencing of more than 41,000 participants in the Ontario Health Study (OHS). It was carried out by the Canadian Data Integration Centre using its genome technology platform, located at the Ontario Institute for Cancer Research (OICR). Such initiatives provide suitable studies to support many broad health research applications where scientists are interested in identifying genetic factors. These factors might be associated with disease development, healthy aging, or enhancing our understanding of how the genome interacts with the environment in terms of disease development. Such applications and the abovementioned factors will require the utilization of biobanks to increase market growth during the forecast period.

Competitive Landscape

The biomedical refrigerator and freezer market is fragmented and consists of several major players. A few significant players currently dominate the market in terms of market share. Some companies currently dominating the market are Thermofisher Scientific Inc., Terumo Corporation, Arctiko, Froilabo SAS, LabRepCo, Philips Kirsch GmbH, PHC Corporations, Haier Biomedical, and Helmer Scientific Inc, among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Burden of Chronic Diseases
    • 4.2.2 Increasing Demand for Organ Transplantation and Biopharmaceuticals
  • 4.3 Market Restraints
    • 4.3.1 High Cost
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product Type
    • 5.1.1 Plasma Freezers
    • 5.1.2 Blood Bank Refrigerators
    • 5.1.3 Laboratory Refrigerators
    • 5.1.4 Laboratory Freezers
    • 5.1.5 Others
  • 5.2 By End User
    • 5.2.1 Hospitals and Clinics
    • 5.2.2 Bio Banks
    • 5.2.3 Others
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Aegis Scientific Inc.
    • 6.1.2 Angelantoni Life Science
    • 6.1.3 Arctiko
    • 6.1.4 Eppendorf AG
    • 6.1.5 Froilabo SAS
    • 6.1.6 Haier Biomedical
    • 6.1.7 Helmer Scientific Inc.
    • 6.1.8 LabRepCo
    • 6.1.9 PHC Corporations
    • 6.1.10 Philips Kirsch GmbH
    • 6.1.11 Terumo Corporation
    • 6.1.12 Thermofisher Scientific Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS